Use of clomiphene citrate in infertile women: a committee opinion

This document reviews the mechanism of clomiphene citrate action, use in women with anovulatory and unexplained infertility, administration, side effects, and alternatives.

Like Comment

Authors

The Practice Committee of the American Society for Reproductive Medicine

Volume 100, Issue 2, Pages 341-348, August 2013

Abstract

This committee opinion describes the use of clomiphene citrate, including indications, use, monitoring, and side effects. There is also a discussion of adjuvants and alternatives to clomiphene citrate therapy.

Earn online CME credit related to this document at www.asrm.org/elearn.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00643-2/fulltext


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.